Trial Profile
The effect of luseogliflozin on epicardial fat accumulation in obese patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jan 2017
Price :
$35
*
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 24 Jan 2017 Status changed from recruiting to completed.
- 17 Nov 2015 New trial record